SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Samuel Johnson Synthetic CCD

PatientSamuel Johnson
Date of birth1970-09-18
IdentifiersMRN HR-EN008-SYN; SSN (made up) 000-08-7139
Document date2026-11-01
AuthorCatriona Bell, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New patient visit for severe recurrent depression and lifelong tics: depression work-up, sertraline and psychotherapy, safety assessment, and a request for neurology consultation. Concerns: He cannot work, cannot face his friends, and fears he is losing his mind; He has lived with movements and sounds he cannot fully control since childhood and wants to know what they are. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 50 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once daily in the morningOral route2026-04-06 to 2026-05-18completedS
Sertraline 100 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once daily in the morningOral route2026-05-18activeS
Ibuprofen 400 mg oral tablet, one tablet by mouth three times daily with food for five daysOne tablet by mouth three times daily with food for five daysOral route2026-08-31 to 2026-09-05completedS
Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth daily while taking ibuprofenOne capsule by mouth daily before breakfast for five daysOral route2026-08-31 to 2026-09-05completedS

Procedures

ProcedureDatesStatusEvidence
Advance care planning conversation, about 18 minutes2026-07-27 to 2026-07-27completedS

Immunizations

DateVaccineStatusEvidence
2026-07-27Recombinant zoster vaccine, dose 1 of 2completedS
2026-07-27Pneumococcal conjugate vaccine PCV20completedS
2026-07-27Tdap vaccinecompletedS
2026-07-27Hepatitis B vaccine (HepB-CpG), dose 1 of 2completedS
2026-09-28Recombinant zoster vaccine, dose 2 of 2completedS
2026-09-28Hepatitis B vaccine (HepB-CpG), dose 2 of 2completedS
2026-09-28Influenza vaccine, 2026-2027 seasoncompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
early childhoodScrofula (king's evil) in early childhood, leaving facial scars and no sight in one eyeD (CLM-0003)
from his youthMotor and vocal tics and ritual stepping and counting behaviors, observed by friends from his youth onwardD (CLM-0009, CLM-0010, CLM-0011, CLM-0012)
1729First severe episode of melancholy at about twenty, with despair and irritability; never afterwards perfectly relievedD (CLM-0004)
1764Very severe return of melancholy, with withdrawal from society, sighing, groaning, and restless pacingD (CLM-0007)

Family History

RelativeConditionAge at deathEvidence
fatherLifelong melancholy, in his son's words "a vile melancholy"; cause of death not recorded in the cited sourceD (CLM-0002)
wifeDied in 1752; cause not recorded in the cited sourceD (CLM-0006)

Health Concerns

ConcernStatusEvidence
He cannot work, cannot face his friends, and fears he is losing his mindactiveS
He has lived with movements and sounds he cannot fully control since childhood and wants to know what they areactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 14.6 on 2026-04-06; Sodium [Moles/volume] in Serum or Plasma 140 on 2026-04-06; Potassium [Moles/volume] in Serum or Plasma 4.3 on 2026-04-06; Creatinine [Mass/volume] in Serum or Plasma 0.98 on 2026-04-06; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 91 on 2026-04-06; Glucose [Mass/volume] in Serum or Plasma 94 on 2026-04-06; Thyrotropin [Units/volume] in Serum or Plasma 2.1 on 2026-04-06; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 412 on 2026-04-06; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 on 2026-04-06; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 7 on 2026-07-27; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 5 on 2026-09-28; Total score [MDQ] 3 on 2026-04-06; Total score [AUDIT-C] 0 on 2026-04-06; Cholesterol [Mass/volume] in Serum or Plasma 212 on 2026-07-27; Cholesterol in HDL [Mass/volume] in Serum or Plasma 46 on 2026-07-27; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 138 on 2026-07-27; Triglyceride [Mass/volume] in Serum or Plasma 140 on 2026-07-27; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 2026-07-27; Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay 0.07 on 2026-07-27; Hepatitis B virus surface Ab [Units/volume] in Serum 2 on 2026-07-27 [S]

Strengths and supports: Widower for thirteen years; shares his home with several longtime friends whom he supports; many close friends, whose company he seeks because he dreads being alone [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Major depressive disorder, recurrent, severe, without psychotic features: low mood, loss of interest, poor sleep, guilt, and withdrawal from company for about three months on a background of depression that never fully lifted after a severe episode last year; first episode at about twenty; synthetic modern episode linked to his documented melancholyactiveconfirmed F33.2S — Synthetic modern diagnosis by DSM-5 criteria; the record makes no claim about his real mental health.
Motor and vocal tics since childhood, with ritual counting and stepping behaviors, never formally diagnosed; neurology evaluation requestedresolvedconfirmed F95.9S — Synthetic presenting concern anchored to the documented tics; superseded by the diagnosis at the neurology consultation.
Tourette syndrome: multiple motor tics and vocal tics since childhood, with premonitory urges, brief suppressibility, and tic-related obsessive-compulsive symptoms (counting, evening-up, and threshold rituals); synthetic modern diagnosis by DSM-5 criteria at the neurology consultation, linked to the documented tics and to the retrospective diagnosisactiveconfirmed F95.2S — Synthetic modern diagnosis; the retrospective historical diagnosis is graded R and is not asserted as fact.
Blindness of the left eye since early childhood after scrofula (tuberculous cervical lymphadenitis), with old scars of the neck and face; right eye myopic, corrected to normal; synthetic modern coding linked to his documented loss of sight in one eyeactiveconfirmed H54.42S — Synthetic modern coding; the source does not say which eye, so the left is a synthetic choice.
Acute low back strain after lifting boxes of books, without radicular symptoms or red flags; treated with heat, activity, and a short course of ibuprofen with stomach protection; resolvedresolvedconfirmed S39.012AS — Synthetic acute problem; not a historical claim.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-04-06Hemoglobin [Mass/volume] in Blood14.6g/dL13.2-17.1 g/dLNormalS
2026-04-06Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-04-06Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2026-04-06Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.74-1.35 mg/dLNormalS
2026-04-06Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M91mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-04-06Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-04-06Thyrotropin [Units/volume] in Serum or Plasma2.1m[IU]/L0.45-4.5 mIU/LNormalS
2026-04-06Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma412pg/mL232-1245 pg/mLNormalS
2026-04-06Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L7-56 U/LNormalS
2026-04-06Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]21{score}S
2026-04-06Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]12{score}S
2026-04-06Total score [MDQ]3{score}S
2026-04-06Total score [AUDIT-C]0{score}S
2026-04-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]19{score}S
2026-05-18Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]15{score}S
2026-05-18Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]9{score}S
2026-06-22Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]10{score}S
2026-09-28Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-09-28Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]5{score}S
2026-07-27Cholesterol [Mass/volume] in Serum or Plasma212mg/dL<=199 mg/dLHighS
2026-07-27Cholesterol in HDL [Mass/volume] in Serum or Plasma46mg/dL>=40 mg/dLNormalS
2026-07-27Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation138mg/dL<=129 mg/dLHighS
2026-07-27Triglyceride [Mass/volume] in Serum or Plasma140mg/dL<=149 mg/dLNormalS
2026-07-27Hemoglobin A1c/Hemoglobin.total in Blood5.5%<=5.6%NormalS
2026-07-27Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay0.07{s_co_ratio}Below 1.00 is nonreactiveNormalS
2026-07-27Hepatitis B virus surface Ab [Units/volume] in Serum2m[IU]/mL10 mIU/mL or more indicates immunityLowS
2026-07-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-04-06Body height183cmS
2026-04-06Body weight98kgS
2026-04-06Body mass index (BMI) [Ratio]29.3kg/m2S
2026-04-06Systolic blood pressure128mm[Hg]S
2026-04-06Diastolic blood pressure80mm[Hg]S
2026-04-06Heart rate84/minS
2026-04-06Respiratory rate16/minS
2026-04-06Body temperature36.7CelS
2026-04-06Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-04-20Body height183cmS
2026-04-20Body weight97.6kgS
2026-04-20Body mass index (BMI) [Ratio]29.1kg/m2S
2026-04-20Systolic blood pressure126mm[Hg]S
2026-04-20Diastolic blood pressure80mm[Hg]S
2026-04-20Heart rate80/minS
2026-04-20Respiratory rate16/minS
2026-04-20Body temperature36.6CelS
2026-04-20Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-05-18Body height183cmS
2026-05-18Body weight98.2kgS
2026-05-18Body mass index (BMI) [Ratio]29.3kg/m2S
2026-05-18Systolic blood pressure124mm[Hg]S
2026-05-18Diastolic blood pressure78mm[Hg]S
2026-05-18Heart rate78/minS
2026-05-18Respiratory rate14/minS
2026-05-18Body temperature36.7CelS
2026-05-18Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-06-22Body height183cmS
2026-06-22Body weight98.6kgS
2026-06-22Body mass index (BMI) [Ratio]29.4kg/m2S
2026-06-22Systolic blood pressure124mm[Hg]S
2026-06-22Diastolic blood pressure78mm[Hg]S
2026-06-22Heart rate76/minS
2026-06-22Respiratory rate14/minS
2026-06-22Body temperature36.6CelS
2026-06-22Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-09-28Body height183cmS
2026-09-28Body weight98.8kgS
2026-09-28Body mass index (BMI) [Ratio]29.5kg/m2S
2026-09-28Systolic blood pressure122mm[Hg]S
2026-09-28Diastolic blood pressure76mm[Hg]S
2026-09-28Heart rate74/minS
2026-09-28Respiratory rate14/minS
2026-09-28Body temperature36.6CelS
2026-09-28Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-07-27Body height183cmS
2026-07-27Body weight98.4kgS
2026-07-27Body mass index (BMI) [Ratio]29.4kg/m2S
2026-07-27Systolic blood pressure124mm[Hg]S
2026-07-27Diastolic blood pressure78mm[Hg]S
2026-07-27Heart rate72/minS
2026-07-27Respiratory rate14/minS
2026-07-27Body temperature36.6CelS
2026-07-27Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-08-31Body height183cmS
2026-08-31Body weight98.6kgS
2026-08-31Body mass index (BMI) [Ratio]29.4kg/m2S
2026-08-31Systolic blood pressure132mm[Hg]S
2026-08-31Diastolic blood pressure82mm[Hg]S
2026-08-31Heart rate82/minS
2026-08-31Respiratory rate14/minS
2026-08-31Body temperature36.7CelS
2026-08-31Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
2026-04-06New patient visit for severe recurrent depression and lifelong tics: depression work-up, sertraline and psychotherapy, safety assessment, and a request for neurology consultationfinishedS
2026-04-20Two-week depression check and neurology consultationfinishedS
2026-05-18Six-week depression review: sertraline dose increase; behavioral therapy for tics under wayfinishedS
2026-06-22Eleven-week review of depression and ticsfinishedS
2026-09-28Six-month review of depression and ticsfinishedS
2026-07-27Periodic adult preventive visitfinishedS
2026-08-31Same-day sick visit for acute low back painfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Sertraline started at 50 mg daily with a two-week tolerability check, and the dose adjusted by the PHQ-9completedGL-CMID-2026, GL-MDD-2022S
Weekly cognitive behavioral therapy for depression, with behavioral activation and work on self-reproachcompletedGL-MDD-2022, GL-CMID-2026S
PHQ-9 at every visit, structured safety assessment with a written safety plan and the 988 Suicide & Crisis Lifeline, safety review at every visit, and a nurse phone check one week after startingcompletedGL-CMID-2026, GL-USPSTF-DEP-2023, GL-SUICIDE-2024S
Neurology consultation to confirm the tic disorder, exclude other movement disorders, assess obsessive-compulsive symptoms, and advise on treatmentcompletedGL-AAN-TICS-2019S
Comprehensive Behavioral Intervention for Tics (CBIT), eight sessions over ten weeks with a trained therapist, with psychoeducation for him and, if he wishes, his householdcompletedGL-AAN-TICS-2019S
Tic severity measured with the Yale Global Tic Severity Scale at the consultation and at three and six months; tic medication held in reservecompletedGL-AAN-TICS-2019S

Goals

GoalTargetStatusOutcomeProvenance
PHQ-9 response (at least a 50% fall) by three months and remission (below 5) by six months2026-09-28completedPHQ-9 10 at eleven weeks (from 21) and 4 at six monthsS
Back at daily writing and seeing friends again by three months2026-06-22completedWriting most mornings and dining with friends several times a weekS
Fewer and less disruptive tics, judged by him and by the tic severity scale, by six months2026-09-28completedYale Global Tic Severity Scale total tic score 22 from 30 and impairment 10 from 20; he finds the remaining tics manageableS
Safety plan in place and reviewed at every visit2026-09-28completedReviewed at every visit; no suicidal thoughts at any visitS

Functional Status

Mental Status

Structured synthetic safety assessment on 2026-04-06: current ideation absent, intent absent, plan absent. Outpatient care with close follow-up because the depression is severe: weekly psychotherapy, a nurse phone check in one week, and a visit in two weeks. No current thoughts of suicide or self-harm, and no firearms or stockpiled medicines at home. A written safety plan was made with him and the 988 Suicide & Crisis Lifeline was given. Safety reviewed at every visit [S]